Schedule 13G ownership disclosure
Arcturus Therapeutics Holdings Inc
Common stock, par value $0.001 per share · CUSIP: 03969T109
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Sumitomo Mitsui Trust Group, Inc.
Shares: 1,926,084.00 · Class: 7.1%
- Nikko Asset Management Co., Ltd.
Shares: 1,926,084.00 · Class: 7.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001214659-25-006367
- Form type
- SCHEDULE 13G/A
- Filer
- Arcturus Therapeutics Holdings Inc.
- CIK
- CIK 1768224
- Filed
- Apr 25, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership